Gastroenterology

Approximately 25% of patients with Crohn’s disease (CD) experience a mild disease course.1 Many of these patients are treated with mesalamine or no th...

We read with interest the recent randomized trial by Rhee et al1 comparing noncontrast magnetic resonance imaging (NC-MRI) and ultrasonography (US) fo...

The recent randomized trial by Rhee et al1 comparing noncontrast magnetic resonance imaging (MRI) and ultrasonography (US) for hepatocellular carcinom...

We read the study from Rhee et al1 with enthusiasm, as we often encounter difficulties in our clinical practice regarding hepatocellular carcinoma sur...

Steatotic liver disease (SLD) affects one-third of the adult population and is mainly driven by cardiometabolic risk factors and alcohol intake.1 Alth...

Serious adverse events (SAEs) are unavoidable occurrences for those performing complex endoscopic interventions. These affect not only the patient (th...

Colorectal cancer (CRC) is the second leading cause of cancer-related deaths in the United States (US).1 Asymptomatic screening leads to earlier detec...

Improving outcomes for pancreatic ductal adenocarcinoma (PDAC) is critical, as current therapies offer limited benefits for most patients. The urokina...

We commend Carlson et al1 for producing a timely consensus on the standardized performance and interpretation of functional lumen imaging probe (FLIP)...

The Dallas Consensus1 is an important document that was overdue to guide endoscopists on how to best perform and interpret functional lumen imaging pr...